{"id":"F2005L00781","name":"National Health Act 1953 - Determination under section 93 (No. PB 6 of 2005)","slug":"national-health-act-1953-determination-under-section-93-no-pb-6-of-2005","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":113066,"registerId":"commonwealth-F2005L00781-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Determination under section 93 (No. PB 6 of 2005)","content":"PBS Determination 93COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDETERMINATION UNDER SECTION 93\n\nNo. PB 6 of 2005\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to section 93 of the National Health Act 1953, hereby make the following Determination:\n\n1. This Determination commences on 1 April 2005.\n2. The Determination under section 93 of the National Health Act 1953 made on 12 July 2004 with effect from 1 August 2004, as amended on 20 December 2004 with effect from 1 February 2005, is repealed.\n3. The pharmaceutical benefits referred to in this Determination shall be those specified in the Schedule to this Determination.\n4. A medical practitioner is authorised for the purpose of section 93 of the National Health Act 1953 to supply any of the pharmaceutical benefits obtained by the medical practitioner, or by another medical practitioner for whom the first-named medical practitioner is temporarily acting as a locum, in pursuance of this Determination.\n5. Subject to this Determination, the maximum quantity or number of units of a pharmaceutical benefit which may be obtained by a medical practitioner in any one month for the purpose of section 93 of the National Health Act 1953 is the quantity or number specified in the Schedule to this Determination in relation to the pharmaceutical benefit.\n6. Where a medical practitioner has obtained a pharmaceutical benefit for the purpose of section 93 of the National Health Act 1953, that medical practitioner is not entitled to obtain a further quantity or number of units of that pharmaceutical benefit for that purpose whilst in possession of a quantity or number of units of the pharmaceutical benefit obtained by the medical practitioner equal to or greater than the maximum quantity or number of units allowed for the pharmaceutical benefit by paragraph 5.\n\n \nTHE SCHEDULE\n\n| Name of pharmaceutical benefit | Form (strength, type, size, etc.) | Maximum quantity |\n| ------------------------------ | --------------------------------- | ---------------- |\n\n```html\n

Adrenaline Acid Tartrate

Injection equivalent to adrenaline 1 in 1,000, 1 mL

5

Atropine Sulfate

Injection 600 micrograms in 1 mL ampoule

10

Benztropine Mesylate

Injection 2 mg in 2 mL ampoule

5

Benzylpenicillin Sodium with any determined brand of sterilised Water for Injections

Injection equivalent to 600 mg benzylpenicillin, vial (with 10 mL ampoule)

10

OR

Procaine Penicillin

Injection 1.5 g in disposable syringe

5

Benzylpenicillin Sodium with any determined brand of sterilised Water for Injections

Injection equivalent to 3 g benzylpenicillin, vial (with 10 mL ampoule)

1

Chlorpromazine Hydrochloride

Injection 50 mg in 2 mL ampoule

10

OR

Haloperidol

Injection 5 mg in 1 mL ampoule

10

Dexamethasone Sodium Phosphate

Injection equivalent to 4 mg dexamethasone phosphate in 1 mL ampoule

5

OR

Hydrocortisone Sodium Succinate

Injection equivalent to 100 mg hydrocortisone with 2 mL solvent

2

OR

Hydrocortisone Sodium Succinate

Injection equivalent to 250 mg hydrocortisone with 2 mL solvent

1

Diazepam

Injection 10 mg in 2 mL ampoule

5

Dihydroergotamine Mesylate

Injection 1 mg in 1 mL ampoule

5

Diphtheria and Tetanus Vaccine - Adsorbed (Diluted)

Injection 0.5 mL in pre-filled syringe

15

Frusemide Sodium

Injection equivalent to 20 mg frusemide in 2 mL ampoule

5

Glucagon Hydrochloride

Injection set containing 1 mg (1 I.U.) and 1 mL solvent in disposable syringe

1

Glyceryl Trinitrate

Buccal/sublingual spray (pump pack) 400 micrograms per dose, 200 doses

1

Lignocaine Hydrochloride

Injection 100 mg in 5 mL ampoule

4

Metoclopramide Hydrochloride

Injection 10 mg in 2 mL ampoule

10

OR

Prochlorperazine Mesylate

Injection 12.5 mg in 1 mL ampoule

10

Morphine Sulfate

Injection 15 mg in 1 mL ampoule

5

OR

Morphine Sulfate

Injection 30 mg in 1 mL ampoule

5

Naloxone Hydrochloride

Injection 800 micrograms in 2 mL disposable injection set

5

OR

Naloxone Hydrochloride

Injection 2 mg in 5 mL disposable injection set

2

Pethidine Hydrochloride

Injection 100 mg in 2 mL ampoule

5

OR

Tramadol Hydrochloride

Injection 100 mg in 2 mL ampoule

5

Promethazine Hydrochloride

Injection 50 mg in 2 mL ampoule

10

Salbutamol Sulfate

Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation)

1

OR

Salbutamol Sulfate

Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30

1

Salbutamol Sulfate

Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30

1

Terbutaline Sulfate

Injection 500 micrograms in 1 mL ampoule

5

Tetanus Vaccine - Adsorbed

Injection 0.5 mL in pre-filled syringe

5

Verapamil Hydrochloride

Injection 5 mg in 2 mL ampoule

5

\n```\n\nDated this twenty second day of March 2005.\n\n| |\n| ------------------------------------------------------------------------------------------------------------------------------------------ |\n| JOAN CORBETTAssistant SecretaryPharmaceutical Benefits BranchDepartment of Health and AgeingDelegate of the Minister for Health and Ageing |","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":2203},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This instrument operates within the established framework of section 93 of the National Health Act 1953, which has historically authorised emergency pharmaceutical benefits for medical practitioners. The determination maintains the traditional 'doctor's bag' scope without expanding into new categories of practitioners or alternative supply arrangements."},"complexity_factors":["Short delegated instrument with only 6 operative clauses plus a schedule","Simple tabular structure listing approximately 30 pharmaceutical items with maximum quantities","Minimal conditional logic (single restriction clause preventing duplicate ordering)","Straightforward administrative mechanism without nested definitions or exceptions","Cross-references limited to the enabling provision (section 93) of the parent Act"],"plain_english_summary":"This instrument authorises medical practitioners to keep a specified set of emergency “doctor’s bag” medicines (e.g., adrenaline, naloxone, morphine, inhalers, certain antibiotics/anti‑nausea) for immediate patient treatment. It limits monthly quantities to prevent stockpiling, allows locums to use supplied items, and replaces earlier lists to reflect current emergency-care needs—primarily affecting GPs and clinicians who provide urgent or after‑hours care."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-determination-under-section-93-no-pb-6-of-2005","history":"/api/acts/national-health-act-1953-determination-under-section-93-no-pb-6-of-2005/history","analysis":"/api/acts/national-health-act-1953-determination-under-section-93-no-pb-6-of-2005/analysis","conflicts":"/api/acts/national-health-act-1953-determination-under-section-93-no-pb-6-of-2005/conflicts","importantCases":"/api/acts/national-health-act-1953-determination-under-section-93-no-pb-6-of-2005/important-cases","documents":"/api/acts/national-health-act-1953-determination-under-section-93-no-pb-6-of-2005/documents"}}